carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane

C82H111N15O9S4Si — CID 165001030

IUPACcarbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane
SMILESCC1CC=C(O[Si](C)(C)C)CC1.CC1CCC(=O)CC1.CC1CCc2nc(N)sc2C1.CC1CCc2nc(Nc3nc4cc(C(=O)NCCOCCO)ccc4n3C)sc2C1.CC1CCc2nc(Nc3nc4cc(C(=O)O)ccc4n3C)sc2C1.CCc1ccc2c(c1)nc(Nc1nc3c(s1)CC(C)CC3)n2C.O=C=O
InChIInChI=1S/C21H27N5O3S.C18H22N4S.C17H18N4O2S.C10H20OSi.C8H12N2S.C7H12O.CO2/c1-13-3-5-15-18(11-13)30-21(24-15)25-20-23-16-12-14(4-6-17(16)26(20)2)19(28)22-7-9-29-10-8-27;1-4-12-6-8-15-14(10-12)19-17(22(15)3)21-18-20-13-7-5-11(2)9-16(13)23-18;1-9-3-5-11-14(7-9)24-17(19-11)20-16-18-12-8-10(15(22)23)4-6-13(12)21(16)2;1-9-5-7-10(8-6-9)11-12(2,3)4;1-5-2-3-6-7(4-5)11-8(9)10-6;1-6-2-4-7(8)5-3-6;2-1-3/h4,6,12-13,27H,3,5,7-11H2,1-2H3,(H,22,28)(H,23,24,25);6,8,10-11H,4-5,7,9H2,1-3H3,(H,19,20,21);4,6,8-9H,3,5,7H2,1-2H3,(H,22,23)(H,18,19,20);7,9H,5-6,8H2,1-4H3;5H,2-4H2,1H3,(H2,9,10);6H,2-5H2,1H3;
InChIKeyIGHWYPVVWPFHOK-UHFFFAOYSA-N
MW1607.24 g/mol
LogP17.27
Rot. Bonds16

About carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane

carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane (PubChem CID 165001030) has the molecular formula C82H111N15O9S4Si and a molecular weight of 1607.24 g/mol. Its IUPAC name is carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane.

Molecular Properties

Compound Namecarbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane
PubChem CID165001030
Molecular FormulaC82H111N15O9S4Si
Molecular Weight1607.24 g/mol
Exact Mass1605.73
IUPAC Namecarbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane
SMILESCC1CC=C(O[Si](C)(C)C)CC1.CC1CCC(=O)CC1.CC1CCc2nc(N)sc2C1.CC1CCc2nc(Nc3nc4cc(C(=O)NCCOCCO)ccc4n3C)sc2C1.CC1CCc2nc(Nc3nc4cc(C(=O)O)ccc4n3C)sc2C1.CCc1ccc2c(c1)nc(Nc1nc3c(s1)CC(C)CC3)n2C.O=C=O
InChIInChI=1S/C21H27N5O3S.C18H22N4S.C17H18N4O2S.C10H20OSi.C8H12N2S.C7H12O.CO2/c1-13-3-5-15-18(11-13)30-21(24-15)25-20-23-16-12-14(4-6-17(16)26(20)2)19(28)22-7-9-29-10-8-27;1-4-12-6-8-15-14(10-12)19-17(22(15)3)21-18-20-13-7-5-11(2)9-16(13)23-18;1-9-3-5-11-14(7-9)24-17(19-11)20-16-18-12-8-10(15(22)23)4-6-13(12)21(16)2;1-9-5-7-10(8-6-9)11-12(2,3)4;1-5-2-3-6-7(4-5)11-8(9)10-6;1-6-2-4-7(8)5-3-6;2-1-3/h4,6,12-13,27H,3,5,7-11H2,1-2H3,(H,22,28)(H,23,24,25);6,8,10-11H,4-5,7,9H2,1-3H3,(H,19,20,21);4,6,8-9H,3,5,7H2,1-2H3,(H,22,23)(H,18,19,20);7,9H,5-6,8H2,1-4H3;5H,2-4H2,1H3,(H2,9,10);6H,2-5H2,1H3;
InChIKeyIGHWYPVVWPFHOK-UHFFFAOYSA-N
XLogP17.27
TPSA323.43 Ų
H-Bond Donors7
H-Bond Acceptors26
Rotatable Bonds16
Heavy Atoms111
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001607.24
LogP ≤ 517.27
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane?
The IUPAC name of carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane (CID 165001030) is carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane.
What is the SMILES notation for carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane?
The canonical SMILES for carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane is CC1CC=C(O[Si](C)(C)C)CC1.CC1CCC(=O)CC1.CC1CCc2nc(N)sc2C1.CC1CCc2nc(Nc3nc4cc(C(=O)NCCOCCO)ccc4n3C)sc2C1.CC1CCc2nc(Nc3nc4cc(C(=O)O)ccc4n3C)sc2C1.CCc1ccc2c(c1)nc(Nc1nc3c(s1)CC(C)CC3)n2C.O=C=O.
What is the InChIKey of carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane?
The InChIKey is IGHWYPVVWPFHOK-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H27N5O3S.C18H22N4S.C17H18N4O2S.C10H20OSi.C8H12N2S.C7H12O.CO2/c1-13-3-5-15-18(11-13)30-21(24-15)25-20-23-16-12-14(4-6-17(16)26(20)2)19(28)22-7-9-29-10-8-27;1-4-12-6-8-15-14(10-12)19-17(22(15)3)21-18-20-13-7-5-11(2)9-16(13)23-18;1-9-3-5-11-14(7-9)24-17(19-11)20-16-18-12-8-10(15(22)23)4-6-13(12)21(16)2;1-9-5-7-10(8-6-9)11-12(2,3)4;1-5-2-3-6-7(4-5)11-8(9)10-6;1-6-2-4-7(8)5-3-6;2-1-3/h4,6,12-13,27H,3,5,7-11H2,1-2H3,(H,22,28)(H,23,24,25);6,8,10-11H,4-5,7,9H2,1-3H3,(H,19,20,21);4,6,8-9H,3,5,7H2,1-2H3,(H,22,23)(H,18,19,20);7,9H,5-6,8H2,1-4H3;5H,2-4H2,1H3,(H2,9,10);6H,2-5H2,1H3;.
What are the key properties of carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane?
carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane has a molecular weight of 1607.24 g/mol, XLogP of 17.27, 16 rotatable bonds, 7 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for carbon dioxide;N-(5-ethyl-1-methylbenzimidazol-2-yl)-6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;N-[2-(2-hydroxyethoxy)ethyl]-1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxamide;4-methylcyclohexan-1-one;1-methyl-2-[(6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)amino]benzimidazole-5-carboxylic acid;6-methyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine;trimethyl-(4-methylcyclohexen-1-yl)oxysilane is sourced from PubChem (CID 165001030), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).